Bone drug targets

QR Code

Bone drug targets

Bibliographic Details
Main Author:	Dass, Crispin
Format:	Journal Article
Published:	2018
Online Access:	http://hdl.handle.net/20.500.11937/67318

Similar Items

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)

p53-targeted cancer pharmacotherapy: move towards small molecule compounds
by: Kim, S., et al.
Published: (2011)

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)

Metabolic stress and cancer: is autophagy the common denominator and a feasible target?
by: Giuliani, C., et al.
Published: (2014)

Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)

Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
by: Ko, S., et al.
Published: (2014)

Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)

Barriers to liposomal gene delivery: From application site to the target
by: Saffari, M., et al.
Published: (2016)

Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy
by: Lin, Daphne, et al.
Published: (2017)

Treatment of bone disorders with parathyroid hormone: Success and pitfalls
by: Ng, P., et al.
Published: (2016)

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: Evidence in silico, in vitro and in vivo
by: Lee, P., et al.
Published: (2016)

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy
by: Hallaj-Nezhadi, S., et al.
Published: (2010)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

Editorial: Current drug targets
by: Sulaiman, Ahmad Hatim, et al.
Published: (2019)

Systemic leptin administration alters callus VEGF levels and enhances bone fracture healing in wildtype and ob/ob mice
by: Wu, Z., et al.
Published: (2018)

Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide
by: Gedawy, A., et al.
Published: (2018)

Drug-targetting of duplex and quadruplex DNA
by: Gavathiotis, Evripidis
Published: (2002)

Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)

Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus
by: Wong, Chun Yuen, et al.
Published: (2018)

Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective
by: Manalo, K., et al.
Published: (2011)

Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

The therapeutic and psychosocial interaction in enhancing drug targets
by: Musa, Ramli, et al.
Published: (2018)

Macromolecules as targeted drugs delivery vehicles: an overview
by: Ali, Yousaf, et al.
Published: (2019)

NMR Studies of Nucleic Acids as Drug Targets
by: Gallagher, Cathal T
Published: (2004)

Polyadenylation as a target for anti-inflammatory drugs
by: Radhi, Masar
Published: (2019)

Targeted bio-distribution of drugs to the lymphatic system
by: Jewell, Adelaide
Published: (2022)

In-silico drug target design & its approaches
by: Abduallah Alsafi, Hassen Mohammed, et al.
Published: (2011)

In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)

Helicobacter pylori biomimics for gastric-targeted drug delivery
by: Hage, N.
Published: (2016)

Development of an EGFR-targeted Drug Delivery System for Glioblastoma
by: Zhao, Zi-Ruo
Published: (2023)